Abstract
Purpose: We present a case of alitretinoin-induced pseudotumor cerebri.Case summary: A 28-year-old woman presented with a 1-month history of bilateral papilledema and intermittent blurred vision in the left eye. She had been taking alitretinoin (9-cis-retinoic acid, Alitoc<sup>Ⓡ</sup>; GlaxoSmithKline) for atopic dermatitis and hand eczema. Although visual acuity remained intact in both eyes, mild central scotoma was detected bilaterally. Optical coherence tomography revealed increased retinal nerve fiber layer thickness in both eyes. Enhanced magnetic resonance imaging revealed no abnormalities except for bilateral flattening of the posterior sclera. Cerebrospinal fluid exhibited an elevated opening pressure (220 mmH<sub>2</sub>O) and a normal composition. Following the discontinuation of alitretinoin, the intermittent blurred vision, papilledema, and central scotoma improved significantly within 2 months.Conclusions: Alitretinoin use should be monitored carefully for a potential development of pseudotumor cerebri, particularly in patients with pre-existing risk factors.mmH2O) and a normal composition. Following
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.